Agitation < Agonist < Agonists

Facettes :

List of bibliographic references indexed by Agonist

Number of relevant bibliographic references: 78.
[40-60] [0 - 20][0 - 50][60-77][60-80]

Ident.	Authors (with country if any)	Title
003B28 (2000)	O. Rascol [France] ; J.-L. Montastruc [France]	La place des agonistes dopaminergiques
003B54 (2000)	L. A. Smith [Royaume-Uni] ; M. G. Jackson [Royaume-Uni] ; C. Bonhomme [France] ; C. Chezaubernard [France] ; K. B. Pearce [Royaume-Uni] ; P. Jenner [Royaume-Uni]	Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset
003B73 (2000)	O. Rascol [France]	Medical treatment of levodopa-induced dyskinesias
003B89 (2000)	H. Allain [France] ; A. Destee [France] ; H. Petit [France] ; M. Patay [France] ; S. Schück [France] ; D. Bentue-Ferrer [France] ; P. Le Cavorzin [France]	Five-year follow-up of early lisuride and levodopa combination therapy versus levodopa monotherapy in de novo Parkinson's disease
003C02 (2000)	C. Imbert [France] ; E. Bezard [France] ; S. Guitraud [France] ; T. Boraud [France] ; C. E. Gross [France]	Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
003C11 (2000)	D. C. Rogers [Royaume-Uni] ; B. Costall [Royaume-Uni] ; A. M. Domeney [France] ; P. A. Gerrard [Royaume-Uni] ; M. Greener [Royaume-Uni] ; M. E. Kelly [Royaume-Uni] ; J. J. Hagan [Royaume-Uni] ; A. J. Hunter [Royaume-Uni]	Anxiolytic profile of ropinirole in the rat, mouse and common marmoset
003C16 (2000)	O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada]	A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa
003C89 (1999)	O.-K. Hassani [France] ; J. Féger [France]	Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study
003D59 (1999)	Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]	Treatment of Parkinson's disease should begin with a dopamine agonist
003E49 (1999)	Jean-Louis Montastruc [France] ; Marc Ziegler [France] ; Olivier Rascol [France] ; Muriel Malbezin [France]	A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease
003E72 (1999)	G. L. Defer [France]	Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
003E73 (1999)	O. Rascol [France]	Arguments en faveur du traitement précoce de la maladie de Parkinson par les agonistes dopaminergiques
003E76 (1999)	M. Ziegler [France] ; P. Rondot [France]	Activité du piribédil dans la maladie de Parkinson : Etude multicentrique
003F14 (1999)		Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients
003F24 (1999)	S. Champagne [France] ; E. Coste [France] ; H. Peyriere [France] ; J. Nigond [France] ; E. Mania [France] ; M. Pons [France] ; D. Hillaire-Buys [France] ; P. Balmes [France] ; J.-P. Blayac [France] ; J.-M. Davy [France]	Chronic constrictive pericarditis induced by long-term bromocriptine therapy : Report of two cases
003F34 (1999)	O. Rascol [France] ; O. Blin [France] ; C. Thalamas [France] ; S. Descombes [France] ; C. Soubrouillard [France] ; P. Azulay [France] ; N. Fabre [France] ; F. Viallet [France] ; K. Lafnitzegger [États-Unis] ; S. Wright [États-Unis] ; J. H. Carter [États-Unis] ; J. G. Nutt [États-Unis]	ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's Disease
003F35 (1999)	H. Bagheri [France] ; C. Damase-Michel [France] ; M. Lapeyre-Mestre [France] ; S. Cismondo [France] ; D. O'Connell [Irlande (pays)] ; J.-M. Senard [France] ; O. Rascol [France] ; J.-L. Montastruc [France]	A study of salivary secretion in Parkinson's disease
004109 (1998)	O. Rascol [France] ; C. Brefel-Courbon [France] ; O. Blin [France]	Pharmacologie clinique des dyskinésies induites par la L-dopa chez les malades parkinsoniens
004125 (1998)	J. M. Senard [France] ; J. L. Montastruc [France]	Approche pharmacologique des dysautonomies
004134 (1998)	A. E. Schrag [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] ; E. Brunt [Pays-Bas] ; D. Fuell [Royaume-Uni] ; A. Korczyn [Israël] ; Werner Poewe [Autriche] ; N. P. Quinn [Royaume-Uni] ; O. Rascol [France] ; F. Stocchi [Italie]	The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease
004137 (1998)	A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; O. Rascol [France] ; F. Stocchi [Italie]	Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Agonist" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Agonist" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Agonist
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024